These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29506477)

  • 1. Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy.
    Giaquinto C; Gabutti G; Baldo V; Villa M; Tramontan L; Raccanello N; Russo F; Poma C; Scamarcia A; Cantarutti L; Lundin R; Perinetti E; Cornen X; Thomas S; Ballandras C; Souverain A; Hartwig S
    BMC Infect Dis; 2018 Mar; 18(1):103. PubMed ID: 29506477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).
    Bernstein HH; Eves K; Campbell K; Black SB; Twiggs JD; Reisinger KS; Conti RM; Flodmark CE; Rombo L; Klopfer S; Schödel F; Hartzel J; Kuter BJ;
    Pediatrics; 2007 Jun; 119(6):e1299-305. PubMed ID: 17502347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.
    Scott LJ
    Paediatr Drugs; 2015 Apr; 17(2):167-74. PubMed ID: 25732634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.
    Baldo V; Baldovin T; Russo F; Busana MC; Piovesan C; Bordignon G; Giliberti A; Trivello R
    BMC Infect Dis; 2009 Sep; 9():150. PubMed ID: 19737419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
    Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
    Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the combined MMRV Priorix-Tetra™ vaccine against varicella in a large Italian region: A case-control study.
    Fortunato F; Musco A; Iannelli G; Meola M; Luigi Lopalco P; Martinelli D
    Vaccine; 2024 Mar; 42(7):1608-1616. PubMed ID: 38341290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).
    Kuter BJ; Brown ML; Hartzel J; Williams WR; EvesiKaren A; Black S; Shinefield H; Reisinger KS; Marchant CD; Sullivan BJ; Thear M; Klopfer S; Xu J; Gress JO; Schödel F;
    Hum Vaccin; 2006; 2(5):205-14. PubMed ID: 17035730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.
    Tafuri S; Fortunato F; Cappelli MG; Cozza V; Bechini A; Bonanni P; Martinelli D; Prato R
    Hum Vaccin Immunother; 2015; 11(1):214-9. PubMed ID: 25483538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
    Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of universal vaccination against varicella in Italy.
    Bechini A; Boccalini S; Baldo V; Cocchio S; Castiglia P; Gallo T; Giuffrida S; Locuratolo F; Tafuri S; Martinelli D; Prato R; Amodio E; Vitale F; Bonanni P
    Hum Vaccin Immunother; 2015; 11(1):63-71. PubMed ID: 25483517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
    Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.